Sangam Health Care Products Ltd

Sangam Health Care Products Ltd has announced that its Board of Directors will convene on November 13, 2026. The primary agenda items include the consideration and approval of the unaudited financial results for the quarter and half-year ended September 30, 2026, along with the Limited Review Report for the same period. The meeting will also address any other business as permitted by the Chair.

Sangam Health Care Products Limited announced the appointment of Mr. T. Abhilash as the Company Secretary and Compliance Officer, effective October 12, 2026. Mr. Abhilash is an associate member of the Institute of Company Secretaries of India and brings experience in corporate legal and secretarial services. He will be responsible for all company secretarial functions as per the Companies Act, 2013, and will also serve as the Compliance Officer under SEBI regulations.

Sangam Health Care Products Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and related BSE circulars. The trading window will be shut from October 1, 2026, and will reopen 48 hours after the declaration of the un-audited financial results for the quarter and half-year ending September 30, 2026. All designated persons and their immediate relatives are prohibited from trading during this period. The date of the board meeting to consider these financial results will be intimated separately.

Sangam Health Care Products Ltd has announced its 32nd Annual General Meeting (AGM) to be held on September 30, 2026. The company has dispatched the soft copy of the Annual Report for FY 2025-26 and the AGM notice to its members. The agenda includes the adoption of the Audited Financial Statements for FY 2025-26, the reappointment of a director retiring by rotation, and the continuation of a non-executive director's directorship.

Sangam Health Care Products Ltd has announced its 32nd Annual General Meeting (AGM) scheduled for September 30, 2026, at 9:00 AM at its registered office. The AGM will cover ordinary business, including the adoption of the Audited Balance Sheet, Profit & Loss, and Cash Flow Statements for the financial year 2025-26, along with auditor and director reports. A key agenda item is the re-appointment of Mr. A. Sai Balaji Krishna Teja, who retires by rotation. Special business includes considering the continuation of Mrs. Padma Ghanakota's directorship.

Sangam Health Care Products Ltd announced the re-appointment of Mr. Bhagat Reddy Dundumulla as Managing Director for a further period of five years, effective September 5, 2026. This decision was made during a board meeting held on August 13, 2026, and is subject to shareholder approval at the upcoming Annual General Meeting (AGM). The board also approved the unaudited financial results for the quarter ended June 30, 2026, and recommended the reappointment of Mrs. Padma Ghanakota. The 32nd AGM is scheduled for September 30, 2026.

Sangam Health Care Products Ltd announced its unaudited financial results for the quarter ended June 30, 2026. The Board of Directors also approved the reappointment of Mr. Bhagat Reddy Dundumulla as Managing Director for a five-year term, subject to shareholder approval. The company will convene its 32nd AGM on September 30, 2026, with the register of members and share transfer books closed from September 24 to September 30, 2026.

Sangam Health Care Products Ltd announced its un-audited financial results for the quarter ended June 30, 2026. The board meeting also approved the reappointment of Mr. Bhagat Reddy Dundumulla as Managing Director for five years, subject to shareholder approval. The company will convene its 32nd Annual General Meeting on September 30, 2026, with the register of members and share transfer books closed from September 24 to September 30, 2026.

Sangam Health Care Products Ltd has announced that its Board of Directors will convene on August 13, 2026. The primary agenda items for this meeting include the consideration and approval of the unaudited financial results for the quarter ended June 30, 2026, along with the associated Limited Review Report. The meeting will also address any other business as permitted by the Chair. The company has provided its registered office address and contact details for further correspondence.

Sangam Health Care Products Ltd has announced the closure of its trading window from July 1, 2026, until 48 hours after the declaration of its unaudited financial results for the quarter ending June 30, 2026. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's code of conduct. All designated persons and their immediate relatives are prohibited from trading in the company's securities during this period. The date for the board meeting to approve these financial results will be communicated separately.